Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Payables (2016 - 2025)

Historic Payables for Iradimed (IRMD) over the last 13 years, with Q3 2025 value amounting to $2.3 million.

  • Iradimed's Payables rose 6661.2% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 6661.2%. This contributed to the annual value of $1.9 million for FY2024, which is 8071.4% down from last year.
  • According to the latest figures from Q3 2025, Iradimed's Payables is $2.3 million, which was up 6661.2% from $1.9 million recorded in Q2 2025.
  • Over the past 5 years, Iradimed's Payables peaked at $9.8 million during Q4 2023, and registered a low of $618217.0 during Q1 2021.
  • For the 5-year period, Iradimed's Payables averaged around $2.0 million, with its median value being $1.4 million (2024).
  • In the last 5 years, Iradimed's Payables soared by 44649.03% in 2023 and then crashed by 8071.4% in 2024.
  • Over the past 5 years, Iradimed's Payables (Quarter) stood at $782903.0 in 2021, then surged by 129.83% to $1.8 million in 2022, then surged by 446.49% to $9.8 million in 2023, then tumbled by 80.71% to $1.9 million in 2024, then rose by 23.05% to $2.3 million in 2025.
  • Its Payables was $2.3 million in Q3 2025, compared to $1.9 million in Q2 2025 and $2.6 million in Q1 2025.